Investigators visit Mass. firm in meningitis case

October 17, 2012

(AP)—Criminal investigators from the Food and Drug Administration have visited a Massachusetts company whose steroid medication has been linked to a deadly meningitis outbreak.

FDA spokesman Steven Immergut said Tuesday the agents' work at the New England Compounding Center is part of the investigation into the outbreak, which has killed at least 15 people and sickened more than 200 others in 15 states. Nearly all the victims had received for back pain.

Company attorney Paul Cirel says it's "difficult to understand the purpose" of the FDA search. He says the company has been clear it would voluntarily provide anything investigators requested. He says the company will continue to cooperate.

Federal and state investigators say they've found in more than 50 vials from the company but haven't said whether they've pinpointed the contamination source.

Explore further: Experts list many ways funguses can taint drugs


Related Stories

Mass. gov: Drug firm may have misled regulators

October 10, 2012

(AP)—Massachusetts Gov. Deval Patrick says the specialty pharmacy linked to a deadly meningitis outbreak may have misled regulators and done work beyond the scope of its state license.

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012

(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

US pharmacy linked to outbreak issues wide recall

October 7, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

New trials offer hope for TB treatment

October 28, 2016

Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.